Your browser doesn't support javascript.
loading
Disposable Component Selection in Extracorporeal Life Support: A Cost Analysis.
Stokes, John W; Gannon, Whitney D; Tipograf, Yuliya; Ukita, Rei; Warhoover, Matthew; Rice, Todd W; Shah, Ashish S; Bacchetta, Matthew.
Afiliação
  • Stokes JW; From the Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Gannon WD; Department of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Tipograf Y; Department of Surgery, Columbia University Medical Center, New York, New York.
  • Ukita R; From the Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Warhoover M; Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Rice TW; Department of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Shah AS; Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bacchetta M; From the Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
ASAIO J ; 67(9): 995-999, 2021 09 01.
Article em En | MEDLINE | ID: mdl-33315654
ABSTRACT
Extracorporeal life support (ECLS) is a resource-intensive technology. Disposable components are modifiable through device selection. Cost analysis tools are needed to inform cost-conscious device selection. We generated a disposable cost analysis to forecast estimated costs of device disposables that included an assumption table, net present value (NPV) analysis, and sensitivity analysis to examine device disposable costs over 5 years with different case volumes and device mixes. To demonstrate the function of the analysis, we included four device options using the following assumptions 100 cases in year 1, 2.5% case growth rate, 10% discount rate, and $5,000 incremental cost (Device 4 only). Using estimated device costs of $3,000, $12,000, $13,000, and $20,000 and device mix percentages of 65%, 8%, 25%, and 2% for Device 1, 2, 3, and 4, respectively, the 5 year unadjusted and NPV of disposable device costs were $3,691,000 and $2,765,000, respectively. The sensitivity analysis incorporated six separate models with different device mix percentages. The highest and lowest estimated costs were found in Model F (75% Device 3 and 25% Device 4; NPV = $6,64,400) and Model B (100% Device 1; NPV = 1,246,000) respectively. Extracorporeal life support programs may apply this disposable cost analysis tool to reduce programmatic costs.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigenação por Membrana Extracorpórea Tipo de estudo: Health_economic_evaluation Idioma: En Revista: ASAIO J Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigenação por Membrana Extracorpórea Tipo de estudo: Health_economic_evaluation Idioma: En Revista: ASAIO J Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article